Basic Information
Gray Matter is a preclinical biotechnology company with research pipelines in the fields of cognitive decline, age-related central nervous system disorders, and anti-aging. Gray Matter is a member of the Lactocore Group, which leverages deep expertise in regulatory peptides, including mammalian regulatory peptides, and a proprietary computer-aided discovery engine to develop novel peptide-based therapies for stress-related metabolic disorders.
Gray Matter
Moscow,MoscowRegion,Russia
15~50 people
January 01, 2021
ir@graymatter.bio

